Inhibitor Therapeutics
(OTC) INTI
Inhibitor Therapeutics Financials at a Glance
Market Cap
$13.81M
Revenue (TTM)
$0.00
Net Income (TTM)
$3.30M
EPS (TTM)
$-0.02
P/E Ratio
-4.19
Dividend
$0.00
Beta (Volatility)
-0.26 (Low)
Dividend
$0.00
Beta (Volatility)
-0.26 (Low)
Price
$0.08
Volume
134,000
Open
$0.10
Price
$0.08
Volume
134,000
Open
$0.10
Previous Close
$0.08
Daily Range
$0.08 - $0.10
52-Week Range
$0.03 - $0.12
Dividend
$0.00
Beta (Volatility)
-0.26 (Low)
Price
$0.08
Volume
134,000
Open
$0.10
Previous Close
$0.08
Daily Range
$0.08 - $0.10
52-Week Range
$0.03 - $0.12
INTI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Inhibitor Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Frank E. O'Donnell, Jr.
Website
www.inhibitortx.comHeadquarters
Tampa, FL 33602, US
INTI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-952%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-23.87%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$13.81M
Shares Outstanding
172.57M
Volume
134.00K
Short Interest
0.00%
Avg. Volume
27.93K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$3.43M
EBITDA
$3.43M
Operating Cash Flow
$3.23M
Capital Expenditure
$0.00
Free Cash Flow
$3.23M
Cash & ST Invst.
$2.38M
Total Debt
$61.61K
Inhibitor Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$13.81M
N/A
Market Cap/Employee
$4.60M
N/A
Employees
3
N/A
Net Income
$1.30M
+8.9%
EBITDA
$1.32M
+7.5%
Quarterly Fundamentals
Net Cash
$2.31M
-58.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$36.89K
N/A
Short Term Debt
$24.72K
N/A
Return on Assets
-1.31%
N/A
Return on Invested Capital
-1.96%
N/A
Free Cash Flow
$601.16K
+22.1%
Operating Cash Flow
$601.16K
+22.1%